Latest literature

Cancer research papers

Nightly index of recent papers from PubMed, bioRxiv, and medRxiv. Filters are designed for both researcher precision and patient-friendly navigation.

Learn how we rate papers in our methodology.

Starting focus

Cholangiocarcinoma

We’re indexing all cancers but highlighting cholangiocarcinoma while the evidence atlas expands.

3 papersSorted by most recent
CDK4/6 inhibition provides additional efficacy in HER2 + , HR + breast cancer.
Nature reviews. Clinical oncology • 2026-02-17 • DOI: 10.1038/s41571-026-01133-2
Peer-reviewedImpact 56

Topics

Not listed

Modality

Not listed

Study type

Not listed

Abstract

Abstract not available.

Authors

David Killock

AI-generated summary

Summary not available yet.

This summary may be inaccurate. Verify with the primary paper.

Primary source: PubMed.

Topics

Treatment

Modality

Targeted therapy

Study type

Review / Meta-analysis

Abstract

Abstract not available.

Authors

Yanmin Deng, Wenrui Huang, Tao Zeng, Yuan Gao

AI-generated summary

Summary not available yet.

This summary may be inaccurate. Verify with the primary paper.

Primary source: PubMed.

Recurrent ERBB2 alterations are associated with esophageal adenocarcinoma brain metastases
genetic and genomic medicine • 2025-02-26 • DOI: 10.1101/2025.02.19.25322558
PreprintImpact 44

Topics

Treatment, Biology / Mechanism, Outcomes / Survival, Epidemiology

Modality

Immunotherapy, Cell therapy, Imaging

Study type

Observational

Abstract

Brain metastases in esophageal adenocarcinoma (EAC) patients are associated with poor prognosis and remain understudied. We performed multi-omics analysis with whole-genome sequencing and single-cell spatial transcriptomics on the brain metastases and matched primary tumors. Our analysis identified ERBB2 as a recurrent oncogene in EAC…

Authors

Lawson, N. M., Ye, L., Cho, C. Y., Zhao, B. +18

AI-generated summary

Recurrent ERBB2 alterations are associated with esophageal adenocarcinoma brain metastases reports: Brain metastases in esophageal adenocarcinoma (EAC) patients are associated with poor prognosis and remain understudied. We performed multi-omics analysis with whole-genome sequencing and single-cell spatial transcriptomics on the brain metastases and matched primary tumors. Our analysis identified ERBB2 as a recurrent oncogene in EAC brain metastases, with 9 out of 10 cases harboring amplifications. This is a preprint and not peer reviewed.

This summary may be inaccurate. Verify with the primary paper.

Primary source: medRxiv (not peer reviewed).